While there's no cure yet for Alzheimer's, researchers are finally making more progress in better understanding the disease ...

Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.

Researchers challenge everything we know about Alzheimer's disease with shocking new findings about amyloid beta protein's ...

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.

The 2024 update to the nation’s roadmap of strategies and actions to address Alzheimer’s disease was released Wednesday by the US Department of Health and Human Services, highlighting federal approval ...

Alzheimer’s disease primarily affects people over the age of 65, but it’s never too early to be aware of the warning signs of this common brain disorder. And you may be able to detect them ...

This article provides an overview of Alzheimer’s disease, including its symptoms, causes, and possible treatment options. Alzheimer’s disease is a condition that affects the brain. Symptoms ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ...

University of Pittsburgh researchers uncovered a surprising link between Alzheimer's disease and herpes simplex virus-1 (HSV-1), suggesting that viral infections may play a role in the disease.

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Axsome Therapeutics is moving ahead with plans to submit its Alzheimer’s disease treatment for Food and Drug Administration approval despite mixed results from two new clinical trial readouts.

Dec. 19, 2024 — Researchers have discovered a surprising link between a chronic gut infection caused by a common virus and the development of Alzheimer's disease in a subset of people.